Healthcare IT & Genomics

Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.

Reports

Structured Reporting Adoption in Imaging IT - World - 2021

This is Signify Research’s 2021 report on the global Structured Reporting Adoption in Imaging IT market.

Find out more

Imaging IT – Core Report - World - 2021

This report provides world market analysis including: Radiology IT (PACS, RIS, EI), Cardiology IT (CVPACS, CVIS, CV-EI), VNA, IE, Advanced Visualisation and Universal Viewing. Full data analysis in 25 country markets.

Find out more

Digital Pathology - World - 2023

This is a brochure for Signify Research’s 2023 report on the global market for Digital Pathology publishing in April 2023.

Find out more

Cloud Adoption in Imaging IT - World - 2020

This is a brochure for Signify Research’s report on the global market for Cloud Adoption in Imaging IT – World – 2020, published in May 2021.

Find out more

Imaging IT – Market Intelligence Service - 2020/2021

This Market Intelligence Service is an annual subscription that provides ongoing data, insights and analysis on the global opportunities for Imaging IT.

Find out more

Imaging IT – Core Report - World - 2020

This report provides world market analysis including: Radiology IT (PACS, RIS, EI), Cardiology IT (CVPACS, CVIS, CV-EI), VNA, IE, Advanced Visualisation and Universal Viewing. Full data analysis in 25 country markets.

Find out more

Analyst Insights

Signify Premium Insight: Perspectum’s Persuasive Value Proposition

Signify Premium Insights Subscription Required

February 2nd 2023 – Perspectum has recently secured $36m in Series C funding. It is a figure that, compared to its peers, is surprisingly low, particularly given Perspectum’s credentials. Is there a reason for this financial modesty?

Signify Premium Insight: Bayer Acquires Blackford as Platforms Become Priority

Signify Premium Insights Subscription Required

January 26th 2023 – Bayer announced it is acquiring AI platform provider Blackford Analysis. Bayer says it will allow Blackford to continue to operate independently, but, is this really the best option?

Signify Premium Insight: The Right Path for Fujifilm

Signify Premium Insights Subscription Required

January 19th 2023 – Fujifilm has taken its partnership with Inspirata a step further, acquiring the vendor’s digital pathology business. It’s a sensible step, but what broader benefits is it also likely to bring?

Signify Premium Insight: When Infrastructure isn’t Enough: Google Offers Algorithms to End-Users

Signify Premium Insights Subscription Required

January 12th 2023 – In its latest move in the medical imaging market, Google has licensed algorithms to AI vendors, Aidence and iCAD. The move gets Google’s products in customers’ hands, but are there any other benefits for the search giant?

Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed?

12th January 2023 – Imogen Fitt of Signify Research attended the 9th Digital Pathology and AI Congress: Europe in December. In the article below she shares her thoughts on the conference with respect to recent industry discourse.